ArticleNeurourology and urodynamics2021

Efficacy and safety of mirabegron in children and adolescents with neurogenic detrusor overactivity: An open-label, phase 3, dose-titration study.

Małgorzata Baka-Ostrowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.